Kind Meds (Cannabis Education Blog)

SEPTEMBER 1, 2020

One of the biggest areas of contention in the public debate about cannabis legalization is the viability of medicinal cannabis as a treatment for many mental health disorders, such as anxiety, depression, bipolar disorder, schizophrenia, and others. Cannabis Is a Unique Substance and Treatment Method. CBD for Mental Health Treatment.

Treatment 122

Treatment Research and Development CBD THC 122

Project CBD

NOVEMBER 11, 2023

In general, I think that botanical medicine is safer than pharmaceutical medicine, that the chances of causing harm are much less. And then cannabis has unique effects for a wide range of conditions, everything from the treatment of pain, treatment of asthma, treatment of immune conditions.

Medicine 309

Medicine Research and Development Pharmaceutical Cannabis 309

MMJ Recs

NOVEMBER 20, 2023

This article delves into the science behind medical marijuana, focusing on cannabinoids, the active compounds found in the cannabis plant, and their remarkable therapeutic effects. We’ll explore the diverse range of cannabinoids and their health benefits, providing insights into how these compounds are revolutionizing healthcare.

Cannabinoids 98

Cannabinoids Epilepsy Treatment Marijuana 98

Veriheal

APRIL 11, 2022

The final goal is to introduce medicinal cannabis products to the pharmaceutical drug market. This means that the medical and scientific communities can now celebrate broader access to research for the production of pharmaceutical products that are safer than smokable or vaporizable cannabis. Drug Enforcement Agency (DEA). Absolutely.”

Pharmaceutical 106

Pharmaceutical Research and Development DEA Clinical Trials 106

Kind Meds (Cannabis Education Blog)

NOVEMBER 18, 2020

In either case, there is definitely a connection, and the widening availability for adults to consume cannabis legally for recreational and medicinal purposes has driven public interest into using cannabis for mental health treatment. Between CBD and THC, CBD seems to hold the best potential as a treatment for anxiety compared to THC.

Treatment 111

Treatment Conditions CBD Clinical Trials 111

FloridaMarijuana.net

JUNE 22, 2018

Ethan Russo suggested that Irritable Bowel Syndrome (IBS), along with fibromyalgia, migraine, and other related conditions, may be linked to an endocannabinoid deficiency ; treatable with cannabinoid medicine. Slowing down gut motility is not the only benefit that cannabis offers to people dealing with IBS.

Hybrid 190

Hybrid Marijuana Sativa Patients 190

Veriheal

SEPTEMBER 18, 2020

Conventional forms of treatment are often accompanied by adverse side effects but there is hope for effective treatment with fewer side effects. . million of NWS Health funding for their Cannabinoid Therapeutics and Brain and Mind Centre to see if cannabidiol can be that effective treatment for spinal cord injury.

Treatment 98

Treatment Chronic Pain CBD Research and Development 98

Veriheal

AUGUST 31, 2020

Most of the conventional methods for treating migraines involve pharmaceutical medication, which has been known to be accompanied by unwanted side effects, especially from opioid based medication. If you have ever suffered through a migraine , you’ll know how much an effective alleviator is necessary. What Does the Study Have to Say?

Treatment 98

Treatment Consumption Indica Hybrid 98

Peninsula Alternative Health

MAY 15, 2019

Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy. However, because cannabinoids reduce seizures through numerous mechanisms of actions, possible drug interactions are still unclear.

Conditions 89

Conditions Therapy Cannabinoids Epilepsy 89

Project CBD

FEBRUARY 1, 2023

Anyone who has paid any attention to the cannabis “wellness” industry in recent years — whether through state medical and recreational programs or the free-for-all national CBD market — will be familiar with cannabinoid-infused topicals marketed to treat minor aches and pains.

Conditions 130

Conditions THC CBD Cannabinoids 130

Puff Puff Post

MARCH 10, 2020

SOURCE InMed Pharmaceuticals Inc. ” Study 755-101-HV is a randomized, vehicle controlled, double-blind, Phase 1 trial, examining the safety and tolerability of two strengths of INM-755 cream in 22 healthy adult volunteers over a 14-day treatment period as part of a randomized, vehicle controlled, double-blind, Phase 1 trial.

Clinical Trials 84

Clinical Trials Pharmaceutical Research and Development Cannabinoids 84

Cannabis Law Report

APRIL 22, 2021

Patent protects Supera-CBD, a preclinical cannabidiol derivative that targets cannabinoid receptor type 2 for the treatment of neuroinflammatory and neurodegenerative… Read More.

Cannabinoids 75

Cannabinoids Pharmaceutical Treatment CBD 75

Cannabis Law Report

JUNE 17, 2021

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) raised its full-year 2021 financial guidance based on the acquisition of GW Pharmaceuticals, which was bought on May 5, 2021. regulatory approval, and our new cannabinoid research platform,” said Renée Galá, the chief financial officer of Jazz Pharmaceuticals.

Pharmaceutical 83

Pharmaceutical Clinical Trials Therapy Programs 83

Cannabis Law Report

DECEMBER 23, 2021

DUBLIN–(BUSINESS WIRE)– “The Pharmaceutical Cannabis Report: 2nd Edition” report has been added to ResearchAndMarkets.com’s offering. This report has been compiled to assist interested parties in understanding the market for the medical use of cannabinoids and where it may be heading. GW Pharmaceuticals.

Pharmaceutical 74

Pharmaceutical Clinical Trials Research and Development Cannabinoids 74

Cannabis Law Report

AUGUST 9, 2021

Cannassure Therapeutics Ltd (TASE: CSURE) (“Cannassure”), an Israel based developer and producer of innovative medical cannabis products, announces today that the company was granted a patent for an oral delivery method of cannabis and cannabinoids compositions by the Israel Patents Authority. Of Cannassure.

Cannabinoids 98

Cannabinoids Pharmaceutical Treatment Patients 98

Cannabis Law Report

JANUARY 3, 2022

AUSTIN, Texas–(BUSINESS WIRE)– Anebulo Pharmaceuticals, Inc. There is a large and growing need to treat acute cannabinoid intoxication with 1.7 million cannabinoid-related emergency department visits in the U.S. About Anebulo Pharmaceuticals, Inc. Anebulo Pharmaceuticals, Inc. Rex Merchant.

Pharmaceutical 52

Pharmaceutical Cannabinoids Treatment Clinical Trials 52

FloridaMarijuana.net

AUGUST 15, 2018

More than ever, cannabis can aid in the treatment of chronic disease and as a supplement to other medical interventions and treatments. The endocannabinoid system consists of cannabinoid receptors all over the body. For centuries, humans have relied on the cannabis plant for its therapeutic properties. Appetite Stimulant.

Chronic Pain 150

Chronic Pain Marijuana Patients Clinical Trials 150

Project CBD

SEPTEMBER 12, 2023

He would undergo a dozen surgeries and consume a steady diet of prescription narcotics and other pharmaceuticals. According to a 2012 study by University of Bonn scientist Andras Bilkei-Gorzo: “On the cellular level, the cannabinoid system regulates the expression of brain-derived neurotrophic factor and neurogenesis.”

Chronic Pain 233

Chronic Pain Treatment Cannabinoids Research and Development 233

Cannabis Info

MARCH 2, 2019

Marijuana as a treatment for epilepsy. Medical cannabis is showing great potential in the treatment of epilepsy. CONVENTIONAL TREATMENT. One of the goals of treating epilepsy is to allow people to continue to live functional and fulfilling life’s epilepsy treatment. CANNABIS AS A POTENTIAL TREATMENT.

Epilepsy 69

Epilepsy Treatment Marijuana Research and Development 69

Project CBD

MAY 3, 2023

Goldstein will be leading the Medical Practicum at CannMed 2023 (May 15-17), where she will also be speaking about CBG and other minor cannabinoids during the main session. You have said that cannabigerol, or CBG, is one of your favorite cannabinoids. Is that because CBG is a precursor for the other plant cannabinoids?

Cannabinoids 214

Cannabinoids Sleep Clinical Trials CBD 214

Cannabis Law Report

JANUARY 12, 2021

IRISYS, LLC, a San Diego-based provider of contract pharmaceutical product development and manufacturing services, today announced that it was awarded… Read More.

Treatment 59

Treatment Cannabinoids Pharmaceutical Law 59

Cannabis Law Report

JULY 1, 2021

As Curaleaf International ‘s subsidiary Adven GmbH seeks to advance its medical cannabis products in Germany, it has teamed up with an Italian pharmaceutical company, Zambon Spa , with whom it will provide medical cannabis treatments for patients, with an initial focus on neurological therapies.

Treatment 71

Treatment Pharmaceutical Therapy Oil 71

Veriheal

AUGUST 12, 2021

million people across the United States , report experiencing improved quality of life and a more restful night’s sleep after consuming the non-psychoactive cannabinoid CBD (cannabidiol). This, the authors say, “is well below the dose commonly associated with pharmaceutical products (e.g. CBD, which constitutes a $2,770.8

Epilepsy 81

Epilepsy Pharmaceutical Patients Sleep 81

Puff Puff Post

DECEMBER 28, 2018

Influencing how information is processed and how nerve cells and synapses in the brain interact, the exact function related to autism is still not well understood, and no pharmaceuticals around yet can ‘fix’ autism. The Current Treatments for Autism. As it sits, only a few methods of treating autism are available.

Treatment 76

Treatment Oil CBD Therapy 76

Veriheal

OCTOBER 13, 2020

Cannabis has been identified as an effective alternative treatment for some gastrointestinal disorders…but does that include IBD and IBS? . Diet is used as the primary treatment. . Dronabinol is commonly used as a treatment in cancer patients due to the fact that it can decrease gut transit and increase colon compliance.

Digestion 125

Digestion Treatment Conditions Research and Development 125

Veriheal

APRIL 7, 2022

Now, a new study has found that medical marijuana (MMJ) shows promise as a treatment for MS. . As with many other conditions, there is a lack of research regarding the use of MMJ as an alternative treatment to relieve symptoms of MS. . The Need for Better MS Treatment. The Need for Better MS Treatment.

Patients 98

Patients Treatment Cannabinoids Pharmaceutical 98

Cannabis Law Report

JULY 26, 2021

SciSparc intends to evaluate the efficacy, safety and tolerability of its Proprietary Cannabinoid-Based Treatment- SCI-110. is a specialty clinical-stage pharmaceutical company led by an experienced team of senior executives and scientists. TEL AVIV, Israel , July 26, 2021 /PRNewswire/ — SciSparc Ltd.

Research and Development 105

Research and Development Supply Chain Pharmaceutical Treatment 105

CannaMD

FEBRUARY 19, 2020

Before getting to this news, let’s take a minute to review some of the prior research supporting marijuana for the treatment PTSD. Medical Marijuana: More Effective Than Pharmaceuticals? To date, there is no pharmaceutical product targeted specifically for the treatment of PTSD. Need Your Medical Marijuana Card?

CBD 111

CBD Pharmaceutical Research and Development Conditions 111

Canna Care Docs

NOVEMBER 4, 2024

cannabis has been used medicinally as a treatment for pain and other ailments. Today, you can explore personalized treatment plans to aid your distinctive needs. Patients with these conditions frequently seek relief from a variety of traditional treatments. Medicine and orthopedic concept. Since 2727 B.C.

Chronic Pain 111

Chronic Pain Nerve Pain Treatment Cannabinoids 111

Cannabis Law Report

AUGUST 6, 2021

CBD, which is an abbreviation for Cannabidiol, is one of Cannabis’s primary components – one of its primary Cannabinoids. Cannabinoids are the naturally occurring compounds found in the Cannabis plant. There are over 480 different Cannabinoids in the Cannabis plant. It’s worth discussing CBD treatment with your dermatologist.

CBD 105

CBD Wellness and Beauty Treatment Pharmaceutical 105

Cannabis Law Report

DECEMBER 6, 2022

Cannabinoid receptors are currently the most popular targets for CNS in preclinical development, with 391 drugs tagged in total. In 2022, a surge in the pipeline has led […].

Cannabinoids 52

Cannabinoids Pharmaceutical Treatment Law 52

United Patients Group

FEBRUARY 7, 2023

The effects of cannabis are caused by cannabinoids, which are chemical compounds found in the resin glands on the leaves and buds of female marijuana plants. Cannabinoids can help with inflammation and pain relief in various ways. Cannabis contains two types of cannabinoids: phytocannabinoids and endocannabinoids.

Cannabinoids 116

Cannabinoids Chronic Pain Terpenes THC 116

Veriheal

MARCH 9, 2021

A team of researchers at Australia’s University of Queensland and at Botanix Pharmaceuticals Limited found, for the first time, that CBD is effective in killing Gram-negative bacteria which could mean that a new class of antibiotics can be developed for bacteria which is resistant to other forms of pharmaceutical medications. .

Research and Development 110

Research and Development Pharmaceutical Cannabinoids CBD 110

Cannabis Law Report

NOVEMBER 12, 2021

THE Chairman of a recently-listed UK pharmaceutically-focused cannabis company has stood down after a breach of market rules. Neil Mahapatra is a co-founder of the Oxford Cannabinoid Technologies (OCT) which floated on the LSE in the May this year, he is also founder of UK venture capital business Kingsley Capital Partners (KCP).

Cannabinoids 98

Cannabinoids Clinical Trials Research and Development Pharmaceutical 98

Veriheal

JANUARY 26, 2023

Most commonly, pharmaceutical medication is prescribed to regulate moods. However, pharmaceutical medications can have side effects, and they may take longer to work for many patients. Thus, this groundbreaking study laid the foundation for understanding how cannabinoids can support mental health.

Treatment 98

Treatment Cannabinoids Conditions Pharmaceutical 98

Cannabis Law Report

JUNE 28, 2021

Pharmaceutical and Medical Cannabis Leaders Zambon GmbH and Adven GmbH will Drive Medical Cannabis Supporting Treatments for Neurological Therapies. The aim of the agreement is to make medical cannabis treatments available to patients, with an initial focus on neurological therapies. The market for medical cannabis in Germany.

Access 105

Access Research and Development Pharmaceutical Therapy 105

Cannabis Law Report

JANUARY 15, 2019

British firm GW Pharmaceuticals is licking its wounds after US judges tossed out its attempt to patent multiple cannabinoids for epilepsy treatment following an eight-year battle. The patent, which has been embroiled in dispute since 2010, is for “the use of one or more cannabinoids in the treatment of epilepsy”.

Epilepsy 71

Epilepsy Cannabinoids Treatment Research and Development 71